Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference
February 19, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, Feb.…
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results…
Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
New Patent expands patent estate covering Adial’s unique molecular genetic approach to…
EYLEA HD (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting
EYLEA HD led to improved vision with extended dosing intervals, achieving non-inferior…
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
February 06, 2025 16:35 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 04, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, Feb.…
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 03, 2025 17:42 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Feb.…
Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer
Results from DENALI Part 1b show an Objective Response Rate (ORR) of…
India-Sierra Leone Trade Ties: Strategic Partnership Opportunities in Pharmaceuticals, IT, and Industrial Development Explored
C. Krishna Shankar Appointed Honorary Trade Commissioner KOCHI, India, Jan. 28, 2025 /PRNewswire/…
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Investigational Review Board (IRB) approval has been granted for the open-label study…